Summary

● In a short-term perspective, the company has interesting fundamentals.


Strengths

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.39 for the 2021 fiscal year.

● With a P/E ratio at 11.7 for the current year and 9.84 for next year, earnings multiples are highly attractive compared with competitors.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.


Weaknesses

● The stock is close to a major daily resistance at EUR 29.24, which should be gotten rid of so as to gain new appreciation potential.

● As estimated by analysts, this group is among those businesses with the lowest growth prospects.

● The company has insufficient levels of profitability.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

● The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.

● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.